Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

about

Current therapeutic landscape for advanced gastroesophageal cancers.New therapeutic options opened by the molecular classification of gastric cancer.

P2860

Q52581752-FCF3104B-FCC4-4995-97E2-09ABB9877BAA Q55527185-BEC619F5-35A3-44AD-9182-DC7B8A479216

P2860

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Item

http://www.wikidata.org/entity/Q47100522

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@en

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@nl

type

Item

label

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@en

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@nl

prefLabel

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@en

Trastuzumab beyond progression ...... oma: a multicenter AGEO study.

@nl

P1476

Trastuzumab beyond progression ...... noma: a multicenter AGEO study

@en

P2093

Astrid Pozet

http://www.w3.org/2001/XMLSchema#string

Aziz Zaanan

http://www.w3.org/2001/XMLSchema#string

Christine Rebischung

http://www.w3.org/2001/XMLSchema#string

Christophe Louvet

http://www.w3.org/2001/XMLSchema#string

Cédric Lecaille

http://www.w3.org/2001/XMLSchema#string

David Sefrioui

http://www.w3.org/2001/XMLSchema#string

Emilie Soularue

http://www.w3.org/2001/XMLSchema#string

Florence Leroy

http://www.w3.org/2001/XMLSchema#string

Francesco Savinelli

http://www.w3.org/2001/XMLSchema#string

Franck Bonnetain

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer.

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

P304

101383-101393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20711

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Tougeron

Benoit Rousseau

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29254172

http://www.w3.org/2001/XMLSchema#string

P932

5731882

http://www.w3.org/2001/XMLSchema#string

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

about

P2860

P2860

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932